LIVE Symposium
Friday, February 24, 2023
11:00 AM - 2:00 PM Eastern Time
Researchers develop immunotherapies based on cancer mutations that produce neoantigens. These proteins are unique to tumors and facilitate immune system activation. Researchers predict neoantigens using sequencing methodologies and develop modified immune cells including T cells, NK cells, and dendritic cells.
In this symposium brought to you by The Scientist’s Creative Services Team, researchers will highlight tools and resources used to hunt for neoantigens and discuss how neoantigen T cell receptors (TCRs) are proving effective in destroying tumors.
Symposium program
11:00 AM – Introduction
11:10 AM – Hitting the target: endogenous T cell responses to pediatric tumor neoantigens
Paul Thomas, PhD
11:45 AM – Drugging intracellular targets with antibodies
David Scheinberg, MD, PhD
12:20 PM – Understanding the fate of neoantigen-specific T cells in cancer
Ingunn Stromnes, PhD
12:55 PM – Tools to interrogate antigen presentation in vivo
Alex Jaeger, PhD
1:30 PM - Open panel Q&A session
Deanna MacNeil from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.
 | Paul Thomas, PhD |
 | David Scheinberg, MD, PhD |
 | Ingunn Stromnes, PhD Assistant Professor Microbiology and Immunology University of Minnesota |
 | Alex Jaeger, PhD Assistant Member, Molecular Oncology Moffitt Cancer Center |